QL2106 Injection

QL2106 · Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QL2106 Injection, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Clinical Study of QL2106 Injection [Phase 3]